Romulo Colindres, MD, MPH, MBA

Chief Executive Officer at VitriVax

Romulo Colindres, MD, MPH, MBA has an extensive work experience in the field of healthcare, with a focus on vaccines and epidemiology. Romulo currently serves as the Chief Executive Officer at VitriVax, where they oversee the company's operations and strategic direction. Prior to this role, they held the position of Chief Medical Officer at VitriVax, where they provided medical leadership and guidance.

Before joining VitriVax, Dr. Colindres founded and served as the Principal Advisor at Global REC. In this role, they advised biotech and pharma companies on various aspects of their business, including business development, medical affairs, epidemiology, clinical development, and pharmacovigilance. Romulo had a specific focus on bringing innovative technologies and novel vaccines to the market.

Dr. Colindres also has a significant experience working at GSK, where they held several leadership positions. Romulo served as the VP Global Medical Affairs Lead for the Zoster Vaccine, overseeing medical affairs activities related to the vaccine. Romulo also served as the Clinical R&D and Medical Affairs Head for GSK Vaccines Brazil, where they were responsible for clinical development and medical affairs activities. Additionally, they held the role of Head of Global Epidemiology at GSK Vaccines, leading epidemiological research and analysis for the organization. Before that, they served as the Director of Epidemiology, Health Economics, and Safety for GSK Vaccines in Latin America.

Dr. Colindres began their career at the Centers for Disease Control and Prevention (CDC) as an Epidemic Intelligence Service Officer. In this role, they gained valuable experience in public health and epidemiology.

Overall, Dr. Colindres' work experience reflects their expertise in vaccine development, medical affairs, epidemiology, and business development.

Romulo Colindres, MD, MPH, MBA has completed multiple degrees in different fields. Romulo obtained a Doctor of Medicine (MD) degree from the University of North Carolina at Chapel Hill. Following their medical degree, they pursued a Master of Public Health (MPH) degree from the same institution. Additionally, Romulo Colindres completed a Master of Business Administration (MBA) degree from Duke University's Fuqua School of Business. While specific details such as start and end years or the field of study for each degree are not provided, it can be inferred that they have a diverse educational background encompassing medicine, public health, and business administration. Moreover, they hold a certification in Pediatrics, however, the institution and the year of certification are not specified.

Links

Timeline

  • Chief Executive Officer

    June 1, 2022 - present

  • Chief Medical Officer

    November 1, 2019

View in org chart